Aravive, Inc.
USD0.04
-0.01 (-13.39%)
CEO
Fredric N. Eshelman
IPO Date
2014-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.04
Prev. Close
$0.05
Day Low
$0.04
Day High
$0.05
52W Low
$0.04
52W High
$2.46
Market Cap
$0.00B
Volume
4.04M
| -1.2 |
| 31 Dec 2020 | FY | -209.9% | -602.3% | -71.3% | -50.6% | 0.18 | 5.65 | -2.6 |
| 31 Dec 2019 | FY | -170.1% | -426.1% | -29.3% | -24.7% | 0.15 | 26.25 | -7.8 |
| 31 Dec 2018 | FY | 100.0% | -5567.7% | -127.3% | -109.9% | 0.12 | 29.42 | -0.3 |
| 31 Dec 2017 | FY | 100.0% | -212.4% | -102.7% | -90.6% | 0.07 | 14.51 | -0.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -63.4% | -46.6% | 0.00 | 3.69 | -4.8 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -46.6% | -44.3% | 0.00 | 20.63 | -4.4 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -34.4% | -33.0% | 0.00 | 24.63 | -7.4 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -172.9% | -126.0% | 0.05 | 3.58 | -39.5 |
| 1.7 |
| 31 Mar 2023 | Q1 | -967.4% | -5499.6% | 212.4% | -190.5% | -0.09 | 1.93 | -0.5 |
| 31 Dec 2022 | Q4 | -1118.0% | -2604.1% | -360.2% | -61.8% | 0.59 | 2.73 | -0.5 |
| 30 Sept 2022 | Q3 | -276.7% | -295.2% | -97.3% | -34.7% | 0.31 | 1.59 | -0.4 |
| 30 Jun 2022 | Q2 | 100.0% | -1070.1% | -57.5% | -30.9% | 0.17 | 2.39 | -0.4 |
| 31 Mar 2022 | Q1 | 100.0% | -904.6% | -25.2% | -13.4% | 0.15 | 3.49 | -1.0 |
| 31 Dec 2021 | Q4 | 100.0% | -1315.3% | -30.7% | -19.1% | 0.15 | 3.22 | -0.9 |
| 30 Sept 2021 | Q3 | 100.0% | -459.6% | -20.4% | -14.4% | 0.13 | 5.04 | -1.7 |
| 30 Jun 2021 | Q2 | 100.0% | -187.5% | -11.1% | -8.3% | 0.12 | 6.87 | -4.3 |